Skip to content
Recall Observatory FDA recall evidence

Drug product

Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by Pfizer Inc. New York, NY 10017, NDC 60793-855-01

D-0339-2019

December 06, 2018

Class II

Product summary

Firm
Pfizer Inc.
Event
Event 81731
Status
Terminated
Classification
Class II
Quantity
1996 bottles
Official record key
drug-enforcement:D-0339-2019

Official wording

Reason: Superpotent Drug.

Code information: Lot #:18A18, Exp. 01/2020

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Superpotent